Curanex Pharmaceuticals Inc CURX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2025-08-26
Curanex Pharmaceuticals Inc statistics & valuation
Market cap$7.5M
P / B0.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Return on assets | -36.5% | -69.8% |
| Return on equity | -37.7% | -71.8% |
| Current ratio | 81.93 | 35.54 |
Source: SEC EDGAR filings · CIK 0002025942 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.